Krishen Sud decreased its stake in Celgene Corp Com Stk (CELG) by 8.33% based on its latest 2017Q3 regulatory filing with the SEC. Sivik Global Healthcare Llc sold 5,000 shares as the company’s stock declined 3.49% while stock markets rallied. The hedge fund run by Krishen Sud held 55,000 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $8.02M, down from 60,000 at the end of the previous reported quarter. Sivik Global Healthcare Llc who had been investing in Celgene Corp Com Stk for a number of months, seems to be less bullish one the $66.43 billion market cap company. The stock increased 0.05% or $0.04 during the last trading session, reaching $88.31. About 7.56 million shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since March 22, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.
Flow Traders Us Llc increased its stake in Novo Nordisk A/S (NVO) by 183.54% based on its latest 2017Q3 regulatory filing with the SEC. Flow Traders Us Llc bought 9,979 shares as the company’s stock rose 15.20% with the market. The institutional investor held 15,416 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $742,000, up from 5,437 at the end of the previous reported quarter. Flow Traders Us Llc who had been investing in Novo Nordisk A/S for a number of months, seems to be bullish on the $121.96B market cap company. The stock decreased 0.53% or $0.27 during the last trading session, reaching $50.25. About 894,945 shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since March 22, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.
Flow Traders Us Llc, which manages about $928.44M US Long portfolio, decreased its stake in Ishares Msci Singapore Capped by 22,361 shares to 99,537 shares, valued at $2.43 million in 2017Q3, according to the filing. It also reduced its holding in Vanguard Total World Stock Etf (VT) by 565,617 shares in the quarter, leaving it with 120,265 shares, and cut its stake in Proshares Ultra Gold (UGL).
Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 21 analyst reports since August 28, 2015 according to SRatingsIntel. BNP Paribas upgraded the shares of NVO in report on Tuesday, September 13 to “Outperform” rating. As per Thursday, September 1, the company rating was downgraded by Morgan Stanley. The stock has “Neutral” rating by JP Morgan on Friday, December 29. The rating was upgraded by HSBC to “Hold” on Wednesday, August 31. The company was upgraded on Wednesday, December 6 by Bank of America. The rating was downgraded by Citigroup to “Neutral” on Monday, October 31. The firm has “Conviction Buy” rating by Goldman Sachs given on Monday, February 15. Leerink Swann initiated Novo Nordisk A/S (NYSE:NVO) on Friday, August 28 with “Market Perform” rating. The stock has “Underperform” rating by Bank of America on Friday, October 28. DNB Markets downgraded Novo Nordisk A/S (NYSE:NVO) on Monday, October 31 to “Hold” rating.
Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on April, 26. They expect $1.78 EPS, up 16.34% or $0.25 from last year’s $1.53 per share. CELG’s profit will be $1.34 billion for 12.40 P/E if the $1.78 EPS becomes a reality. After $1.87 actual EPS reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -4.81% negative EPS growth.
Since September 25, 2017, it had 1 insider purchase, and 4 insider sales for $3.83 million activity. $851,093 worth of Celgene Corporation (NASDAQ:CELG) was sold by LOUGHLIN JAMES J on Monday, March 12. $1.26M worth of Celgene Corporation (NASDAQ:CELG) was sold by MARIO ERNEST. The insider KAPLAN GILLA sold 18,500 shares worth $1.77M. On Monday, September 25 the insider Curran Terrie sold $248,498.
Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 2 Sell and 13 Hold. Therefore 56% are positive. Celgene Corporation had 139 analyst reports since July 21, 2015 according to SRatingsIntel. On Friday, October 20 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm earned “Buy” rating on Thursday, January 7 by Suntrust Robinson. The firm has “Buy” rating given on Friday, August 4 by Cowen & Co. The stock of Celgene Corporation (NASDAQ:CELG) has “Strong-Buy” rating given on Tuesday, September 1 by Raymond James. The firm has “Buy” rating given on Thursday, July 6 by Stifel Nicolaus. On Wednesday, November 9 the stock rating was downgraded by Standpoint Research to “Hold”. The firm has “Hold” rating by JMP Securities given on Friday, October 27. The rating was maintained by Cantor Fitzgerald on Thursday, July 27 with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Tuesday, September 19 by Robert W. Baird. The company was maintained on Tuesday, April 19 by Credit Suisse.
Sivik Global Healthcare Llc, which manages about $250.21 million and $293.92M US Long portfolio, upped its stake in Wellcare Health Plans Inc Com Stk (NYSE:WCG) by 10,000 shares to 45,000 shares, valued at $7.73M in 2017Q3, according to the filing. It also increased its holding in Smith & Nephew Plc Adr (NYSE:SNN) by 30,000 shares in the quarter, for a total of 120,000 shares, and has risen its stake in Agilent Technologies Inc Com Stk (NYSE:A).
Investors sentiment decreased to 1.17 in Q3 2017. Its down 0.17, from 1.34 in 2017Q2. It dropped, as 44 investors sold CELG shares while 457 reduced holdings. 133 funds opened positions while 451 raised stakes. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. Montag A Assoc owns 7,601 shares. Sands Ltd Liability Company holds 4,130 shares or 0% of its portfolio. Brown Lc owns 29,620 shares. Wendell David Assoc accumulated 92,735 shares or 2.39% of the stock. Ubs Asset Mgmt Americas Inc accumulated 6.03 million shares. Narwhal Capital Mgmt stated it has 8,840 shares. Zevenbergen Cap Invests Limited Company invested 3.8% of its portfolio in Celgene Corporation (NASDAQ:CELG). Vigilant Capital Mgmt holds 0.07% in Celgene Corporation (NASDAQ:CELG) or 3,054 shares. Banced Corp has invested 1.04% in Celgene Corporation (NASDAQ:CELG). Woodstock Corp reported 98,530 shares. Boston Family Office Lc holds 2.24% or 135,238 shares. Aqr Capital Limited Liability Corporation has invested 0.35% in Celgene Corporation (NASDAQ:CELG). Tompkins Financial Corp owns 17,437 shares. 2.68M were reported by Fred Alger Management. New England Mngmt Inc holds 10,834 shares or 1.16% of its portfolio.